明達醫 (6527)
明達醫 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$84.27M, up 9.8% from a year earlier. EPS over the last four quarters totals NT$5.87.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2019-12-25
- Founded
- 2009-10-26
- Paid-in capital
- NT$254.59M
- Common shares issued
- 25,458,550
- Legal name
- 明達醫學科技股份有限公司
- Website
- http://www.crystalvue.com.tw
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$84.27M | +31.7% | +9.8% |
| 2026-08 | NT$63.96M | -12.5% | -2.8% |
Year to date: -8.0% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 1.68 |
| 2026 Q1 | 1.33 |
| 2025 Q4 | 1.49 |
| 2025 Q3 | 1.37 |
| 2025 Q2 | 1.48 |
| 2025 Q1 | 1.46 |
| 2024 Q4 | 1.18 |
| 2024 Q3 | 1.32 |
Last four quarters: NT$5.87
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.90 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 965 | 0.4% |
| 1,000–5,000 shares | 837 | 6.0% |
| 5,001–10,000 shares | 101 | 2.8% |
| 10,001–15,000 shares | 45 | 2.1% |
| 15,001–20,000 shares | 33 | 2.3% |
| 20,001–30,000 shares | 26 | 2.5% |
| 30,001–40,000 shares | 17 | 2.3% |
| 40,001–50,000 shares | 14 | 2.5% |
| 50,001–100,000 shares | 23 | 6.7% |
| 100,001–200,000 shares | 19 | 10.3% |
| 200,001–400,000 shares | 13 | 15.9% |
| 400,001–600,000 shares | 3 | 5.9% |
| 600,001–800,000 shares | 2 | 5.5% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 2 | 34.8% |
TDCC data for 2026-10-16: 2 holders own more than 1,000 lots (34.8% of shares), and 965 hold less than one lot (0.4%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -1 | 0 | 0 | -1 |
| 2026-10-16 | 1 | 0 | 0 | 1 |
| 2026-10-15 | 4 | 0 | 0 | 4 |
| 2026-10-08 | -2 | 0 | 0 | -2 |
| 2026-10-06 | -1 | 0 | 0 | -1 |
| 2026-10-05 | -3 | 0 | 0 | -3 |
| 2026-10-02 | -2 | 0 | 0 | -2 |
| 2026-10-01 | -1 | 0 | 0 | -1 |
| 2026-09-30 | -1 | 0 | 0 | -1 |
| 2026-09-29 | -1 | 0 | 0 | -1 |
| 2026-09-24 | 5 | 0 | 0 | 5 |
| 2026-09-23 | 1 | 0 | 0 | 1 |
| 2026-09-22 | -5 | 0 | 0 | -5 |
| 2026-09-18 | -1 | 0 | 0 | -1 |
| 2026-09-17 | 2 | 0 | 0 | 2 |
| 2026-09-16 | 1 | 0 | 0 | 1 |
| 2026-09-15 | -1 | 0 | 0 | -1 |
| 2026-09-14 | -5 | 0 | 0 | -5 |
| 2026-09-11 | -3 | 0 | 0 | -3 |
| 2026-09-10 | -3 | 0 | 0 | -3 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net sellers of 16 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$72.20 (2026-10-19); 52-week range NT$66.30–84.00.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.